These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 4547337)

  • 1. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft-versus-host and cytotoxic activity of rat thoracic duct lymphocytes fractionated by zonal centrifugation after culture on allogeneic fibroblasts.
    Bowers WE
    J Immunol; 1974 Oct; 113(4):1252-61. PubMed ID: 4153365
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
    Husberg BS
    Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.
    Kedar E; Otiz de Landazuri M; Fahey JL
    J Immunol; 1974 Jan; 112(1):26-36. PubMed ID: 4812174
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens.
    Ting CC; Law LW
    J Immunol; 1977 Apr; 118(4):1259-64. PubMed ID: 191534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction.
    Glaser M; Herberman RB; Kirchner H; Djeu JY
    Cancer Res; 1974 Sep; 34(9):2165-71. PubMed ID: 4276482
    [No Abstract]   [Full Text] [Related]  

  • 11. Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens.
    Dennert G
    J Immunol; 1974 Jul; 113(1):201-8. PubMed ID: 4208918
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic approach to cancer.
    Mitchison NA
    Transplant Proc; 1970 Mar; 2(1):92-103. PubMed ID: 4107297
    [No Abstract]   [Full Text] [Related]  

  • 13. Phagocytic cells as effectors in a cell-mediated immunity system.
    Dennert G; Lennox ES
    J Immunol; 1973 Dec; 111(6):1844-54. PubMed ID: 4543031
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E; Bonavida B
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
    Treves AJ; Carnaud C; Trainin N; Feldman M; Cohen IR
    Eur J Immunol; 1974 Nov; 4(11):722-7. PubMed ID: 4547711
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity in hyperacute kidney rejection: tests for detecting presensitization.
    Thomas FT; Thomas JM; Fawley JC; Volk M; Burke SG; Wolf JS; Lee HM
    Surg Forum; 1974; 25(0):270-3. PubMed ID: 4612774
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.
    De Landazuri MO; Herberman RB
    J Natl Cancer Inst; 1972 Jul; 49(1):147-54. PubMed ID: 5037432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.